
Sign up to save your podcasts
Or
In this episode, we interview Christina Campero, an entrepreneurial force behind Prosperia, a tech startup focused on AI in healthcare. Christina discusses her professional journey, moving from a background in bioscience and healthcare consulting to co-founding Prosperia. The startup uses AI to scan retina images for early detection of diabetic retinopathy and other eye diseases, a crucial service in Mexico due to a high prevalence of diabetes and limited access to ophthalmologists. The conversation covers the development process of their AI model, partnerships with primary healthcare touchpoints, and the advantages of operating in Mexico. They also explore the challenges and breakthroughs in fundraising for a Latin American AI healthcare startup, including securing a seed round from a Swedish fund. The episode ends with a look at Prosperia’s future goals, including expanding their AI applications to detect other health conditions.
If your company is looking to scale its AI initiatives, head over to Tesoro AI (www.tesoroai.com). We are experts in AI strategy, staff augmentation, and AI product development.
Founder Bio:
Cristina Campero graduated from the Faculty of Chemistry of the UNAM with a Master's Degree in Bioscience Enterprise from the University of Cambridge in the United Kingdom. She has dedicated her professional career to the transformation of ideas into commercial products with an impact on health, starting in her career as a consultant at McKinsey & Company and in start-ups, first as an Associate in business development and strategy at Wren Therapeutics (in Cambridge UK ) where she was in charge of portfolio prioritization and funding (£18M Series A in Dec. 2018), and now as CEO of PROSPERiA.
Time Stamps:
00:36 Christina's Professional Journey
04:00 Founding Prosperia and Developing Retinia
05:43 Addressing Diabetic Retinopathy with AI
07:10 Challenges in Diabetic Retinopathy Detection
09:32 AI's Role in Early Detection and Screening
13:33 How does the Retinia software diagnosis work
15:20 The role of AI versus human doctors
20:43 Building and Training AI Models
24:31 Balance between engineers and health care professionals
26:14 Creating a customer base that trusts AI diagnosis
32:53 Fundraising and Growth Strategies
40:45 Advantages of Fundraising in Latin America Compared to the U.S.
44:01 Future Plans and Innovations
Resources
Follow Darius Gant
LinkedIn - https://www.linkedin.com/in/m-darius-gant-cpa-44650aa/
Company Website - www.tesoroai.com
Subscribe on Spotify:
https://open.spotify.com/show/4uDVNgsK3iNeu7yU4Inu2n
Subscribe on Apple Podcast:
https://podcasts.apple.com/ae/podcast/the-darius-gant-show/id1527996104
Company website: https://www.prosperia.health/es
LinkedIn: https://www.linkedin.com/company/prosperia/
https://www.linkedin.com/in/cristina-campero-peredo-a87a15115/
5
5151 ratings
In this episode, we interview Christina Campero, an entrepreneurial force behind Prosperia, a tech startup focused on AI in healthcare. Christina discusses her professional journey, moving from a background in bioscience and healthcare consulting to co-founding Prosperia. The startup uses AI to scan retina images for early detection of diabetic retinopathy and other eye diseases, a crucial service in Mexico due to a high prevalence of diabetes and limited access to ophthalmologists. The conversation covers the development process of their AI model, partnerships with primary healthcare touchpoints, and the advantages of operating in Mexico. They also explore the challenges and breakthroughs in fundraising for a Latin American AI healthcare startup, including securing a seed round from a Swedish fund. The episode ends with a look at Prosperia’s future goals, including expanding their AI applications to detect other health conditions.
If your company is looking to scale its AI initiatives, head over to Tesoro AI (www.tesoroai.com). We are experts in AI strategy, staff augmentation, and AI product development.
Founder Bio:
Cristina Campero graduated from the Faculty of Chemistry of the UNAM with a Master's Degree in Bioscience Enterprise from the University of Cambridge in the United Kingdom. She has dedicated her professional career to the transformation of ideas into commercial products with an impact on health, starting in her career as a consultant at McKinsey & Company and in start-ups, first as an Associate in business development and strategy at Wren Therapeutics (in Cambridge UK ) where she was in charge of portfolio prioritization and funding (£18M Series A in Dec. 2018), and now as CEO of PROSPERiA.
Time Stamps:
00:36 Christina's Professional Journey
04:00 Founding Prosperia and Developing Retinia
05:43 Addressing Diabetic Retinopathy with AI
07:10 Challenges in Diabetic Retinopathy Detection
09:32 AI's Role in Early Detection and Screening
13:33 How does the Retinia software diagnosis work
15:20 The role of AI versus human doctors
20:43 Building and Training AI Models
24:31 Balance between engineers and health care professionals
26:14 Creating a customer base that trusts AI diagnosis
32:53 Fundraising and Growth Strategies
40:45 Advantages of Fundraising in Latin America Compared to the U.S.
44:01 Future Plans and Innovations
Resources
Follow Darius Gant
LinkedIn - https://www.linkedin.com/in/m-darius-gant-cpa-44650aa/
Company Website - www.tesoroai.com
Subscribe on Spotify:
https://open.spotify.com/show/4uDVNgsK3iNeu7yU4Inu2n
Subscribe on Apple Podcast:
https://podcasts.apple.com/ae/podcast/the-darius-gant-show/id1527996104
Company website: https://www.prosperia.health/es
LinkedIn: https://www.linkedin.com/company/prosperia/
https://www.linkedin.com/in/cristina-campero-peredo-a87a15115/